Market closed
BioLife Solutions/$BLFS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BioLife Solutions
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Ticker
$BLFS
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
159
Website
BLFS Metrics
BasicAdvanced
$1.2B
-
-$0.44
2.04
-
Price and volume
Market cap
$1.2B
Beta
2.04
52-week high
$29.55
52-week low
$14.84
Average daily volume
337K
Financial strength
Current ratio
4.545
Quick ratio
3.475
Long term debt to equity
5.114
Total debt to equity
5.114
Interest coverage (TTM)
-9.92%
Management effectiveness
Return on assets (TTM)
-1.10%
Return on equity (TTM)
-3.32%
Valuation
Price to revenue (TTM)
14.035
Price to book
3.37
Price to tangible book (TTM)
9.25
Price to free cash flow (TTM)
407.069
Growth
Revenue change (TTM)
8.44%
Earnings per share change (TTM)
-71.65%
3-year revenue growth (CAGR)
-11.62%
3-year earnings per share growth (CAGR)
23.99%
What the Analysts think about BLFS
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for BioLife Solutions stock.
BLFS Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
BLFS Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for BioLife Solutions stock?
BioLife Solutions (BLFS) has a market cap of $1.2B as of March 14, 2025.
What is the P/E ratio for BioLife Solutions stock?
The price to earnings (P/E) ratio for BioLife Solutions (BLFS) stock is 0 as of March 14, 2025.
Does BioLife Solutions stock pay dividends?
No, BioLife Solutions (BLFS) stock does not pay dividends to its shareholders as of March 14, 2025.
When is the next BioLife Solutions dividend payment date?
BioLife Solutions (BLFS) stock does not pay dividends to its shareholders.
What is the beta indicator for BioLife Solutions?
BioLife Solutions (BLFS) has a beta rating of 2.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.